Please Wait.....
Report
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
Market Report I 2025-01-10 I 134 Pages I IMARC Group
The global congestive heart failure drugs market size reached USD 9.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.62% during 2025-2033. The rising prevalence of obesity and cardiovascular problems, increasing geriatric population and unhealthy dietary habits represent some of the key factors driving the market.
Congestive heart failure is a medical condition that affects the pumping ability of the heart muscle. It is generally caused by hypertension, coronary artery disease, diabetes, obesity, and excessive alcohol consumption. Its symptoms include shortness of breath while lying down, weakness, fatigue, swelling in the abdomen, feet, and ankles, frequent urination at night, nausea, and difficulty in concentration. It can be prevented by maintaining a healthy weight, staying physically active, and controlling blood pressure and glycemic levels. Besides this, it is controlled using various prescribed drugs that help prevent blood clots, expand blood vessels, strengthen the contractions of the heart, and improve heart functioning. At present, ACE inhibitors, vasodilators, digitalis glycosides, diuretics, and beta-blockers are some of the most prescribed congestive heart failure drugs. Amongst these, ACE inhibitors prevent the formation of angiotensin, which causes blood vessels to constrict, and beta blockers block the actions of certain chemicals.
Presently, the increasing global geriatric population, which is highly susceptible to diabetes and chronic cardiovascular diseases, represents one of the major factors positively influencing the market. In addition, excessive smoking and drinking of alcoholic beverages, coupled with unhealthy dietary habits of individuals, increases the risks of heart problems, which is catalyzing the demand for congestive heart failure drugs across the globe. This, coupled with the rising occurrence of heart problems due to obesity and lack of physical activity, is currently strengthening the growth of the market. Furthermore, the increasing awareness among individuals about the benefits of early diagnosis and treatment of heart disease is creating a positive outlook for the market. Apart from this, the escalating demand for effective drugs and treatment and their approval from authorized agencies offer lucrative growth opportunities to the leading market players. Moreover, initiatives undertaken by governments of various countries to improve healthcare infrastructure and provide optimal care to patients are contributing to the growth of the market. Additionally, the expansion of pharmacies in hospitals and residential areas and the burgeoning e-commerce industry providing easy availability of medicines at affordable rates and the facility of secured online payment methods are expected to propel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global congestive heart failure drugs market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on drug class, route of administration, and distribution channel.
Drug Class Insights:
ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Diuretics
Aldosterone Antagonists
Inotropes
Others
The report has also provided a detailed breakup and analysis of the congestive heart failure drugs market based on the drug class. This includes ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, and others. According to the report, ACE inhibitors represented the largest segment.
Route of Administration Insights:
Oral
Intravenous
A detailed breakup and analysis of the congestive heart failure drugs market based on the route of administration has also been provided in the report. This includes oral and intravenous. According to the report, the oral route of administration accounted for the largest market share.
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
A detailed breakup and analysis of the congestive heart failure drugs market based on the route of administration has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (The United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest market for congestive heart failure drugs. Some of the factors driving the North America market included the development of healthcare infrastructure, increasing cases of heart failure and the easy availability of technologically advanced devices and innovative drugs.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global congestive heart failure drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG), Novartis AG, etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. How big is the global congestive heart failure drugs market?
2. What is the expected growth rate of the global congestive heart failure drugs market during 2025-2033?
3. What are the key factors driving the global congestive heart failure drugs market?
4. What has been the impact of COVID-19 on the global congestive heart failure drugs market?
5. What is the breakup of the global congestive heart failure drugs market based on the drug class?
6. What is the breakup of the global congestive heart failure drugs market based on the route of administration?
7. What is the breakup of the global congestive heart failure drugs market based on the distribution channel?
8. What are the key regions in the global congestive heart failure drugs market?
9. Who are the key players/companies in the global congestive heart failure drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Congestive Heart Failure Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 ACE Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Angiotensin 2 Receptor Blockers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Beta Blockers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Diuretics
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Aldosterone Antagonists
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Inotropes
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Novartis AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
?Figure 1: Global: Congestive Heart Failure Drugs Market: Major Drivers and Challenges
Figure 2: Global: Congestive Heart Failure Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Congestive Heart Failure Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Congestive Heart Failure Drugs Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Congestive Heart Failure Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Congestive Heart Failure Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Congestive Heart Failure Drugs (Beta Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Congestive Heart Failure Drugs (Beta Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Congestive Heart Failure Drugs (Diuretics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Congestive Heart Failure Drugs (Diuretics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Congestive Heart Failure Drugs (Inotropes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Congestive Heart Failure Drugs (Inotropes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Congestive Heart Failure Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Congestive Heart Failure Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Congestive Heart Failure Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Congestive Heart Failure Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Congestive Heart Failure Drugs Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Congestive Heart Failure Drugs Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Congestive Heart Failure Drugs Industry: Value Chain Analysis
Figure 83: Global: Congestive Heart Failure Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Congestive Heart Failure Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Congestive Heart Failure Drugs Market: Competitive Structure
Table 7: Global: Congestive Heart Failure Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security